Atrial fibrillation trials in Japan
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleStroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
- Where
- Higashiibaraki District, Kanagawa, Kawanishi, Kyoto, Sapporo, Tsuchiura, Yokohama
- Age
- 18 years and over
- People
- 15,364 worldwide
- Run by
- Regeneron Pharmaceuticals
See details and how to joinNCT07626411 · EU 2025-521617-97-00 - No phaseNot yet taking people in JapanHead-to-Head (H2H) Comparison of Ambulatory Cardiac ECG Monitors in Japan
- Where
- Gifu, Nagoya
- Age
- 18 years and over
- People
- 130
- Run by
- iRhythm Technologies, Inc.
See details and how to joinNCT07870837 - No phaseTaking peopleNovel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- Where
- Nagoya, Tōon
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Oslo University Hospital
See details and how to joinNCT07436299 - Phase 3Taking peopleStudy to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- Where
- Akashi, Chikushino-shi, Chūōku, Funabashi-Shi, Hamada-shi, Hamamatsu, Himeji-Shi, Imabari, Isehara-Shi, Kōtoku, Kure-shi, Matsue, Matsumoto-Shi, Nagano, Naha, Okayama, Ōmihachiman, Osaka, Sapporo, Sendai, Shimonoseki-shi, Tachikawa-shi, Tochigi, Tokushima, Tokyo, Tōon, Toyama, Urayasu, Uwajima-Shi, Yokohama
- Age
- 65 years and over
- People
- 2,500 worldwide
- Run by
- Anthos Therapeutics, Inc.
See details and how to joinNCT05712200 · EU 2023-503224-66-00 - No phaseTaking peopleEvaluating the Accuracy and Practical Utility of AI-Enhanced 12-Lead ECG
- Where
- Ōta-ku
- Age
- 18 years to 99 years
- People
- 350
- Run by
- Toho University
See details and how to joinNCT07316231 - No phaseTaking peoplePulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation
- Where
- Sagamihara
- Age
- 18 years to 85 years
- People
- 300
- Run by
- Kitasato University
See details and how to joinNCT07064616 - Phase 4Taking peopleNon-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
- Where
- Bunkyo-ku, Chiyoda-ku, Fuchū, Gifu, Isehara, Katsushika-ku, Kawasaki, Kitakyushu, Kurashiki, Matsudo, Nagoya, Okayama, Ōsaka-sayama, Ōta-ku, Sapporo, Sendai, Shinjuku-ku, tabashi City, Toyama, Toyohashi
- People
- 500
- Run by
- OCEAN-SHD Study Group
See details and how to joinNCT07125417